Instead of relying on genetic engineering, MosquitoMate infects laboratory-grown mosquitoes with the common bacterium Wolbachia pipientis, which affects mosquitoes rather than animals or humans. Male mosquitoes (non-bite humans) infected with Wolbachia pipientis mate with wild populations of female Asian tiger mosquitoes (biting humans). Due to the role of bacteria, the paternal chromosomes can not be formed normally, MosquitoMate mosquito fertilized eggs will not hatch, so as to achieve the purpose of mosquito control.
MosquitoMate plans to distribute this genus of male mosquitoes in 20 U.S. states and Washington, DC this summer. Though the idea of mosquito control is good, MosquitoMate laboratory technicians still have to manually remove the male and female mosquitoes Separately, this process is very time-consuming.
Given that millions of these laboratory mosquitoes must be released in cities to curb the number of wild mosquitoes, companies may have to consider creating a faster and more effective way to separate mosquitoes from both sexes. Previously, laboratory-grown GM mosquitoes have been successfully tested in countries such as China and Brazil. However, MosquitoMate hopes to use non-GMO solutions to destroy deadly mosquitoes and preserve our environment in a more natural way.